Skip to content
Two clinics in Hyderabad.Two clinics in Hyderabad: Banjara Hills and Manikonda.Visit us

How we decide what to offer

What we offer, what we refuse, and why.

A longevity clinic can sell almost anything. These are the questions a test or therapy has to clear before we offer it, the things we turn down, and how your physician decides what, if anything, suits you.

Last updated

Before we offer anything

Four questions. All four, every time.

  1. Is there human evidence?

    Trials in people or guideline support, not only a plausible mechanism or a mouse study. We grade what we find on three tiers and show the tier on every treatment page. Emerging therapies are offered only with that label and an honest account of what is not known.

  2. Is it safe enough for the reason it is used?

    Known risks, interactions and who should not have it. A physician screens your history, medicines and blood results before any therapy, and a risk that outweighs the likely benefit rules it out.

  3. May it be offered in India?

    Medicines are prescribed by a physician only where clinically indicated, and only medicines approved for use in India. We do not offer drugs without Indian marketing approval, and we do not offer approved medicines for uses regulators have warned against.

  4. Can we measure whether it works for you?

    There has to be a marker, a scan or a test we can repeat, and a date to repeat it. If nothing can show whether a therapy is helping you, we cannot tell you honestly that it is.

The evidence label you will see on each treatment

Established
Backed by large studies or guidelines and part of standard practice.
Strong & indicated
Well supported when your results or diagnosis call for it, and only then.
Emerging
Plausible biology and early human data. We tell you what is and is not known.
How we grade the evidence

Considered and declined

What we do not offer, and the reason for each.

Some of these are sold by other clinics in India. We decline them because they fail one or more of the four questions above.

  • Unapproved peptides

    The injectable "research peptides" sold for recovery or ageing have no marketing permission in India. Under the New Drugs and Clinical Trials Rules, 2019 they are new drugs, which may be used only in an approved trial. Peptides are not part of any Genoryx membership.1

  • Stem cell treatments

    India’s national guidelines say any use of stem cells in patients outside an approved clinical trial is malpractice, with the exception of blood stem cell transplants for approved conditions.2

  • Exosome and other cell-derived products

    Products derived from cells or stem cells are classed as new drugs under the same 2019 rules and need approval before use. We do not offer them for skin, hair or ageing.1

  • Chelation for the heart, or to “clean out” the body

    Chelation treats proven heavy-metal poisoning. In a 2024 trial of 959 people with diabetes and a previous heart attack, chelation infusions did not reduce heart attacks, strokes or deaths compared with placebo.3

  • Tumour markers sold as a cancer screen

    A single blood marker is not a reliable cancer screen for people without symptoms. For ovarian cancer, the US Preventive Services Task Force found that screening does not reduce deaths and that false positives lead to unnecessary surgery.4

  • Cosmetic or "anti-ageing" injections

    We do not inject products for skin lightening, and we do not offer glutathione as an anti-ageing treatment. India’s drug regulator has warned clinics against injecting cosmetic products.5

  • Cure, reversal and guaranteed results

    Indian law forbids advertising a medicine to prevent or cure premature ageing, and the evidence does not support the promise. Your retest shows what moved and what did not, and we show you both.6

For you, specifically

Your physician decides with you. None is a valid answer.

Passing the four questions makes a therapy available. It does not make it right for you. That is decided at your consultation, from your results.

  1. 01

    Start from your results

    Every recommendation has to trace to a measured marker or to your history. Fashion is not a reason.

  2. 02

    Weigh it with you

    The physician explains the evidence tier, the risks, the cost and the alternatives, including changing nothing but sleep, food or training.

  3. 03

    You decide

    You can take the plan, part of it, or none of it. The assessment and consultation can be booked on their own.

  4. 04

    Set the retest

    Anything you start gets a date when it is measured again. If the number does not move, the plan changes.

How we write about therapies is covered in our editorial policy.

Questions people ask.

Can a physician decide that I need nothing?

Yes. A normal result is a good outcome, not a prompt to find something to treat. Every recommendation has to trace to a measured marker or your history, and "no therapy, retest in a year" is a valid plan.

Do you offer peptide therapy?

No. Peptides are not a feature of any Genoryx membership. If a prescription medicine is clinically indicated for you, your physician discusses the evidence and risks with you first and prescribes only medicines approved for use in India.

Why do you offer therapies labelled Emerging?

Some therapies have plausible biology and early human data but no large trials yet, such as red light or NAD+. We offer them only after screening, label them Emerging, and tell you plainly what is and is not known.

Do you offer stem cells or exosomes?

No. Outside an approved clinical trial, India’s national guidelines treat stem cell use in patients as malpractice, and cell-derived products are regulated as new drugs.

Will you try to sell me IV drips?

No. IV therapy is offered only after a physician has screened you and only when a measured reason supports it. We never bundle spa or aesthetic treatments into an assessment.

Sources

  1. 1.Central Drugs Standard Control Organisation. New Drugs and Clinical Trials Rules, 2019 (as amended). (opens in a new tab)
  2. 2.Nature India. India bans commercial use of stem cells for therapy (ICMR-DBT National Guidelines for Stem Cell Research, 2017), 2017. (opens in a new tab)
  3. 3.Lamas GA, et al. Edetate disodium-based chelation for patients with a previous myocardial infarction and diabetes: TACT2 randomized clinical trial. JAMA, 2024. (opens in a new tab)
  4. 4.US Preventive Services Task Force. Screening for ovarian cancer: recommendation statement. JAMA, 2018. (opens in a new tab)
  5. 5.Medical Dialogues. Glutathione drips and injectable aesthetic procedures under CDSCO lens, 2026. (opens in a new tab)
  6. 6.Drugs and Cosmetics Rules, 1945, Rule 106 and Schedule J: diseases and ailments a drug may not claim to prevent or cure, including premature ageing. (opens in a new tab)

Your biological age is a number you can measure.

Start with the 400+ parameter entry assessment and a 60-minute physician consultation at either Hyderabad clinic. Open seven days, 11 AM to 9 PM.

Book a consultation